Compositions and methods for detecting Epstein Barr Virus (EBV)

A technology for detecting viruses and samples, which is applied in the field of in vitro diagnostics and can solve problems such as the complexity of actual virus diversity and characteristics

Pending Publication Date: 2022-03-11
F HOFFMANN LA ROCHE & CO AG
View PDF22 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

EBV genetic diversity has been reported to generally include the two types listed in the literature, but the actual diversity profile of the virus is more complex and may depend on which part of the genome is sampled

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for detecting Epstein Barr Virus (EBV)
  • Compositions and methods for detecting Epstein Barr Virus (EBV)
  • Compositions and methods for detecting Epstein Barr Virus (EBV)

Examples

Experimental program
Comparison scheme
Effect test

example

[0098] The following examples and figures are provided to aid in the understanding of the present invention, the true scope of which is set forth in the appended claims. It should be understood that modifications may be made in the procedures set forth without departing from the spirit of the invention.

[0099] The test is fully automated sample preparation (nucleic acid extraction and purification) followed by PCR amplification and detection. The system used is 6800 / 8800System, which consists of sample supply module, transfer module, processing module and analysis module. Automated data management by 6800 / 8800System execution.

[0100] The master mix contains detection probes specific for EBV and control nucleic acids. The specific EBV and control detection probes are each labeled with one of two unique fluorochromes that serve as reporters. Each probe also has a second dye that acts as a quencher. Reporter dyes are measured at defined wavelengths, allowing detection...

example 1

[0102] Example 1: Design of primers and probes for detection of EBV by real-time PCR

[0103] The EBV nucleic acid test was designed with two targets in mind. The two targets chosen were BMRF2 and EBNA1 and are shown in Figure 1. These candidates can be used individually or dually together in dual target assays. If used as a dual target assay, two sets of primers and probes (each detecting EBNA1 or BMRF2) were employed. As shown in Table 1 above, the primers for the BMRF2 target have the nucleic acid sequences of SEQ ID NO: 1 and 3, and the probe for the BMRF2 target has the nucleic acid sequence of SEQ ID NO: 2. In addition, as shown in Table 1 above, the primers for the EBNA1 target have the nucleic acid sequences of SEQ ID NO: 4 and 6, and the probe for the EBNA1 target has the nucleic acid sequence of SEQ ID NO: 5. The amplicon generated by the primers targeting BMRF2 is a 96 base pair long amplicon, and as figure 2 shown (and where primers and probes overlap the am...

example 2

[0104] Example 2: EBV Primers and Probes to Detect BMRF2 and EBNA-1 of EBV in a Real-Time PCR Assay

[0105] The EBV nucleic acid assay was tested using primers / probes for detection of BMRF2 (SEQ ID NO: 1-3) and EBNA1 (SEQ ID NO: 4-6). A complete procedure for the EBV assay was run. Four types of EBV-containing samples were used: (1) EBV-infected Raji cell extracts spiked into EBV-negative plasma; (2) extracted EBV DNA (extracted from the B95-8 cell line from AdvancedBiotechnologies (Cat. No. 17-926-500)); (3) Qnostics EBVAnalytic Panel (EBV1604009C); and (4) 1 of EBV st WHO International Standard. The reagents used include 6800 / 8800 Universal PCR Master Mix, with Features and conditions for use with the 6800 / 8800, and the use of Amplification and detection techniques. The final concentration of oligonucleotides in the master mix was 0.3 μM for primers and 0.1 μM for probes. adopted The 6800 / 8800PCR Profile is shown in Table 2 below:

[0106]

[0107] Table 2 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Described herein are methods for the rapid detection of the presence or absence of Epstein Barr virus (EBV) in a biological or non-biological sample. The method may include performing an amplification step, a hybridization step, and a detection step. In addition, EBV-targeting primers and probes as well as kits designed to detect a target region of EBV are provided. Kits, reaction mixtures, and oligonucleotides (e.g., primers and probes) for amplifying and detecting EBV are also described. Primers and probes that detect different regions of EBV and that can be employed in a dual target assay to simultaneously detect two different and non-overlapping target regions of EBV are also described.

Description

technical field [0001] The present disclosure relates to the field of in vitro diagnostics. Within this field, the present invention relates to the use of primers and probes for the amplification and detection of target nucleic acids that may be present in a sample, in particular for Epstein-Barr virus (EBV) targets involving sequence variations and / or individual mutations. Amplification, detection and / or quantification of nucleic acids. The present invention further provides reaction mixtures and kits containing primers and probes for amplification and detection of EBV. Background technique [0002] Epstein-Barr virus (EBV) is a DNA virus that is a member of the herpesvirus group (its other name is human herpesvirus 4 or HHV-4). EBV infection is common, with an estimated prevalence of 90% in adults, and is usually asymptomatic. EBV infection can cause mononucleosis during its initial lytic phase, followed by one or more of several latent phases. EBV is associated with l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/70C12Q1/686C12N15/11C12R1/93
CPCC12Q1/705C12Q1/686C12Q2600/16C12Q2537/143C12Q2563/107C12Q2561/113C12Q1/701C12Q1/70C12Q2531/113C12Q2561/101C12Q1/6813C12Q1/6844
Inventor A·T·汉密尔顿M·海尔D·利格特J·孙L·王X·吴
Owner F HOFFMANN LA ROCHE & CO AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap